1. Consumers' Optimism Bias and Responses to Risk Disclosures in Direct-to-Consumer (DTC) Prescription Drug Advertising: The Moderating Role of Subjective Health Literacy
2. Aikin, K. J. & O’Donoghue, A. C. (2008). Toll-Free number for reporting adverse events on labeling for human drug products: Labeling comprehension study. Food and Drug Administration. Retrieved from https://www.regulations.gov/document?D=FDA-2003-N-0313-0009
3. Aikin, K. J., Swasy, J. L. & Braman, A. C. (2004). Patient and physician attitudes and behaviors associated with DTC promotion of prescription drugs: Summary of FDA survey research results. Retrieved from https://www.fda.gov/downloads/Drugs/ScienceResearch/ResearchAreas/DrugMarketingAdvertisingandCommunicationsResearch/UCM152860.pdf
4. Anderson, M., Perrin, A. & Jiang, J. (2018, March 5). 13% of Americans don’t use the internet: Who are they? Pew Research Center. Retrieved from http://www.pewresearch.org/fact-tank/2018/03/05/some-americans-dont-use-the-internet-who-are-they/
5. Serious and actionable risks, plus disclosure: Investigating an alternative approach for presenting risk information in prescription drug television advertisements